Blood pressure lowering efficacy of loop diuretics for primary hypertension

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Musini, Vijaya M ^a   Wright, James M ^a   Bassett, Ken ^a   Jauca, Ciprian D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

UBIDECARENONE;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFICACY; DRUG WITHDRAWAL; ESSENTIAL HYPERTENSION; HEART RATE; HUMAN; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 77950122897     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003825.pub2     Document Type: Review

References (51)

1. Bodak 1989 {published data only} Bodak A, Gavardin Th, Salom M, Tarrade Th, Forette F, Jungers P. Efficacy and tolerance of cicletanine in arterial hypertension of the elderly [Efficacite et tolerance cicletanine chez le sujet age hypertendu]. Therapie 1989;44:101-106.
2. Gotzen 1994 {published data only} Gotzen R, Schulte K-L, Bonath Th. Duration of Antihypertensive Effectiveness during Therapy with Cicletanine in Ambulatory 24-h Blood Pressure Measurement [Antihypertensive Wirkdauer von Cicletanin in der ambulanten 24-h-Blutdruckmessung]. Herz/ Kreisl 1994;26(11):377-381.
3. Homuth 1993 {published data only} Homuth V, Faulhaber HD, Loose U, Loffler K, Luft FC. Usefulness of pirentanide plus ramipril for systemic hypertension: A multicenter trial. The American Jornal of Cardiology 1993;72:666-671.
4. Jain 1984 {published data only} Jain AK, Michael R, Ryan JR, McMahon FG. Antihypertensive and biochemical effects of indacrinone enantiomers. Pharmacotherapy 1984;4:278-283.
5. Licata 1989 {published data only} Licata G, Scaglione R, Parrinello G, Capuana G, Piovana U, Ganguzza A, Merlino G. Clinical and hemodynamic effects of etozolin in essential hypertension: A double blind controlled trial. Current Therapeutic Research 1989;45(2):263-267.
6. Perola 1985 {published data only} Perola P, Lehto MB H, Lammintausta R, Vikari J. Metabolic effects of furosemide and the combination of furosemide and triamterene. Current Therapeutic Reserach 1985;37(3):545-553.
7. Vadasz 1982 {published data only} Vadasz TA, Chadha DR. Experience with once daily and twice daily slow release frusemide in hypertension. J Int Med Res 1982;10:199-203.
8. Verho 1986 {published data only} Verho M, Rangoonwala B, Beloso M, Maass L, bender R. Pirentanide in the treatment of essential hypertension. A double blind comparison versus placebo. Drugs Exptl. Clin. Res. 1986;XII (5):385-391.
9. Wertheimer 1973 {published data only} Wertheimer L, Finnerty Jr FA, Bereu BA, Mich E, Hall RH. Furosemide in essential hypertension. A ststistical analysis of three double blind stuides. Archives Internal Medicine 1971;127:934-938.
10. Bonaduce 1981 {published data only} Bonaduce D, Ferrara N, Petretta M, Canonico V, Romango E, rengo F. Comparison of antihypertensive activities of xipamid and chlorthalidone: a double blind randomized cross over trial. Current Medical reserach and Opinion 1981;7(4):247-252.
11. Buckert 1984 {published data only} Buckert C, Muhlhausier W, Fratzer U, verho M. A double blind multicentre study of pirentanide and hydrochlorthiazide in patients with essentail hypertension. J Int Med Res 1984;12:81-86.
12. Campbell 1998 {published data only} Campbell N, Brant R, Stalts H, Stone J, Mahallati H. Fluctuations in blood lipid levels during furosemide therapy. Archives of Internal medicine 1998;158:1461- 1463.
13. Charansonney 1997 {published data only} Charossoney SL, Lievre, Laville M, Lion L et al. Eurieve Study Group. The Eurieve study: contrasting effect of pirentanide and thiazides in mild to moderate hypertension. Therapie 1997;52:169-177.
14. Clerson 1989 {published data only} Clerson P, Deltour L, Billaut P, Tarrade T, Berthet P, Pauchnat M. Efficacy and tolerance of cicletanine added to a previous beta blocking tehrapy in essential hypertensive patients [Evaluation de l'efficacite et de la tolerance du cicletanine chez des patients hypertendus traites par beta-bloquants]. Arch Mal Coeur 1989;82:1293-1297.
15. Di Somma 1990 {published data only} Di Somma S, Liguori V, Petitto M, Galletti P, De Divitis O. The hemodynamic effect of etozolin in teh treatment of hypertension. Current therapeutic Research 1990;48(6):1044-1052.
16. Fried 1979 {published data only} Fried ED. Tienilic acid in the treatment fo hypertension. Double blind assessment of tienilic acid in essential hypertension. Postgraduate Medical Journal 1979;55(Suppl 3):92-97.
17. Galleti 1991 {published data only} Galleti F, Strazzullo P, Barba G, Cappuccio P, Iacone R, Mancici R. Diuretic therapy for mild hypertension: A comparison of the meatbolic effects of etozoline and chlorthalidone during long term treatment. Current Therapeutic Research 1991;50(2):159-166.
18. Gupta 1981 {published data only} Gupta PS, Dave ML. Pirenbtanide (HOE118): A new diuretic in essential hypertension. Current therapeutic reaserch 1981;30(4):468-476.
19. Heijden 1998 {published data only} van der Heijden M, Donders SH, Cleophas TJ, Niemeyer MG, van der Meulen J, Bernink PJ, de Planque B, van der Wall EE. A randomized placebo controlled study of loop diuretics in patients with essential hypertension: teh Bumetanide and furosemide on lipid profile (BUFUL) clinical study report. Journal of Clinical Pharmacology 1998;38:630-635.
20. Holland 1979 {published data only} Holland B, Gomez-Sanchez C, Fairchild C, Kaplan NM. Role of renin classification for diuretic treatment of black hypertensive patients. Arch Internal medicine 1979;139:1365-1370.
21. Jungers 1989 {published data only} Jungers P, Gavardin T, Salom M, Tarrade T, Berthet P. Dosage study of ciclretanine in elderly hypertensive patients: comparison of 50 vs 100mg daily dose [Etude comparative de deux posologies d' un nouvel antihypertenseur, le cicletanine chez le sujet age']. Arch Mal Coeur 1989;82(IV):125-129.
22. Knoben 1982 {published data only} Knobem JM, Chada DR. Clinical experience with a fixed dose combination of penbutolol and furosemide in hypertension. Current Therapeutic Research 1982;31(3):281-292.
23. Kopp 1978 {published data only} Kopp VH. The antihypertensive effect of etozolin [Zur antihypertensiven wirkung des diuretikums etozolin]. Fortschr. Med.96.jg. 1978;22:1194-1198.
24. Krogsgaard 1976 {published data only} Krogsgaard AR, Trap-Jensen J, Hartling O, Svendsen TL. Clinical and hemodynamic effects of high doses of slow release furosemide in arterial hypertension. A double blind cross over study with cyclopenthiazide. Acta Med Scand Suppl 1976;602:110-3. [PUBMED: PMID: 800315]
25. Kumar 1984 {published data only} Kumar S, Pandi p, Wahi PL, Sharma PL. A randomized double blind clinical trial of Xipamid and hydrochlorthiazide in essential hypertension. International Journal of Clinical Pharmacology 1984;22(10):349-331.
26. Kuramoto 1985 {published data only} Kuramoto K, Masuyama Y. Comparison of clinical usefullness of diuretics in elderly and younger essentila hypertension - Double blind trial using tripamide. Jpn J Geriat 1985;22:346-353.
27. Magrini 1988 {published data only} Magrini F, Reggiani P, Roberts N, Meazza R, Ciulla M, Zanchetti A. Effects of angiotensin and angiotensin blockade on coronary circulation and coronary reserve. The American Journal of medicine 1988;84(suppl 3A):55-60.
28. Miziara 1982 {published data only} Miziara LJ, Goncalves JGF, Feres F. Comparative double blind trial with long acting furosemide and chlorthalidone in the treatment of essential hypertension [Ensaio comparativo duplo-cego com furosemide de acao prolongada e chortalidona no tratamento da hipertensao essencial]. Farmacologica Clinica 1982;85(4):773-778.
29. Nami 1991 {published data only} Nami R. Acute antihypertensive, diuretic and metabolic effect of etozolin and chlorthalidone. Pamnivera Med 1991;33:157-163.
30. Obel 1984 {published data only} Obel A, Griffin L, Were J. Comparison of slow release frusemide and bendrofluazide in teh treatment of moderater hypertension in Kenyan Negroes.. Clinical Trials Journal 1984;21(6):443-450.
31. Okun 1978 {published data only} Okun R, Beg Mirza. Tricynafen and hydrochlorthiazide in hypertension. Clin Pharmacol, Ther June 1978;23(6):703-711.
32. Okun 1979 {published data only} Okun R, Beg MA. A double-blind study of tienilic acid with two year follow-up of patients with mild to moderate essential hypertension. Postgrad Med J 1979;55(Suppl 3):103-9. [PUBMED: PMID: 388395]
33. Oli 1983 {published data only} Oli JM, Ikeakor IP. Sustained release frusemide and blood glucose levels in diabetics. Cuurent Therapeutic Research 1983;34(3):537-541.
34. Olshan 1981 {published data only} Olshan AR, O'Connor DT, Preston RA, Frigon RP, Stone RA. Involvement of Kallikrein in the Antihypertensive Response to Furosemide in Essential Hypertension. Journal of Cardiovascular Pharmacology 1981;3(1):161-8.
35. Pearson 1979 {published data only} Pearson RM, Bulpitt CJ, Havard CWH. Biochemical and haematological changes induced by tienilic acid combined with propranolol in essential hypertension. The Lancet 1979 March 31;1 (8118):697-9. [PUBMED: PMID: 85937]
36. Pearson RM, Bulpitt CJ, Havard CWH. Propranolol and tienilic acid in essential hypertension. Postgraduate Medical Journal 1979;55(3): 115-119.
37. Potter 1987 {published data only} Potter JF, Beevers DG. Atenolol improves blood pressure control in patients taking captopril and frusemide. Journal of Human Hypertension 1987;1:127-130.
38. Reyes 1990 {published data only} Reyes AJ, Chiesa PD, Santucci MR, Batista LB, Olhaberry JV, Mosler AL, Mignone AM, Leary WP, Queiruga G. Hydrochlorthiazide versus a non-diuretic dose of torasemide as once daily antihypertensive monopharmacotharapy in elderly patients. A randomized douible blind study.. Progress in Pharmacology and clinical Pharmacology 1990;8(1):183-209.
39. Ronchi 1990 {published data only} Ronchi E, Posca M, Sassi S, Agostara F, Palumbo G. Adding muzolimine or triamterene to nifedipine: effect on blood pressure. Current Therapeutic Research September 1990;48(3):492-498.
40. Rutledge 1988 {published data only} Rutledge J, Ayers C, Davidson R, DiPette D, Guthrie G, Fisher M, Schwartz S, Rucinska E. Effect of intravenous enalaprilat in moderate and severe systemic hypertension. The American Journal of Cardiology 1988;62:1062-1067.
41. Valmin 1980 {published data only} Valmin K, Hansen T, Ronsted P. Treatment of benign essential hypertension with frusemide in different doses. Pharmacotherapeutica 1980;2:296-304.
42. Webster 1987 {published data only} Webster J, Petrie JC, Robb OJ, Witte K, Lovell HG. Atenolol or propanolol in hypertensive patients poorly controlled on captopril and frusemide. Journal of Human Hypertension 1987;1:121-126.
43. Yasky 1987 {published data only} Yasky J, Verho M, Rangoonwala B. Efficacy of a fixed dose combination of 40mg penbutolol with 6 mg pirentanide in the treatment of mild to moderate hypertension: a double blind study against placebo. Curr. Med. Res. Opi. 1987;10(6):397-406.
44. Yasky J, Verho M, Rangoonwala B. Efficacy of a low dose fixed combination of penbutolol and pirentanide in teh treatment of mild to moderate hypertension: a double blind study against placebo. Pharmatherapeutica 1986;4(9):607-16. [PUBMED: PMID: 3763655]
45. Heran 2008a Heran BS, Wong MMY, Heran IK,Wright JM. Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: CD003823. DOI: 10.1002/14651858.CD003823.pub2]
46. Heran 2008b Heran BS, Wong MMY, Heran IK,Wright JM. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: CD003822. DOI: 10.1002/ 14651858.CD003822.pub2]
47. Materson 1983 Materson BJ. Insights into intrarenal sites and mechanism of action of diuretic agents. American heart Journal 1983;106:188-208.
48. Musini 2008 Musini VM, Fortin PM, Bassett K, Wright JM. Blood pressure lowering efficacy of renin inhibitors for primary hypertension. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: CD007066. DOI: 10.1002/14651858.CD007066.pub2]
49. Musini 2009 Musini VM, Wright JM. Factors affecting blood pressure variability: Lessons learned from two systematic reviews of randomized controlled trials . PLOS ONE 22 May 2009;4(5): e5673. [DOI: 10.1371/journal.pone.0005673]
50. Seldin 1997 Seldin Donald, Giebisch Gerhard. Diuretic agents: clinical physiology and pharmacology. San Diego, California: Academic Press, 1997.
51. Wright 2009 Wright JM, Musini VM. First line treatment of hypertension. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD001841.pub2]